TagsImmunotherapy

Tag: immunotherapy

Healthcare

AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer

Ravindra Soni - April 13, 2026 0

Healthcare

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer

Ravindra Soni - April 1, 2026 0

Corporate

Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Ravindra Soni - January 15, 2026 0

Healthcare

Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India's First Novel Immunotherapy for Advanced Small Cell Lung Cancer

Ravindra Soni - August 5, 2025 0

Entertainment

Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America

Ravindra Soni - November 3, 2023 0

Most Read

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

TukTuki streams ‘What Is Dyslexia’ film for Dyslexia Awareness Month

November 4, 2026

EDITOR PICKS

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

POPULAR POSTS

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.